Questcor Pharmacueticals, Inc. (QCOR) Tops Q4 EPS by 5c

Questcor Pharmacueticals, Inc. (NASDAQ: QCOR) reported Q4 EPS of $0.47, $0.05 better than the analyst estimate of $0.42. Revenue for the quarter came in at $75.5 million versus the consensus estimate of $72.77 million.

For earnings history and earnings-related data on Questcor Pharmacueticals, Inc. (QCOR) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• Investing.com’s stocks of the week
• Benchmark Reiterates Buy Rating on Malibu Boats (MBUU) on Significant Earnings Upside